6472 — Bora Pharmaceuticals Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual cashflow statement for Bora Pharmaceuticals Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	595	1,024	1,840	4,064	4,955
Depreciation
Amortisation
Non-Cash Items	-337	70.6	197	1,269	-1,172
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-221	-68.1	-352	-1,325	-3,828
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	178	1,237	2,010	4,614	981
Capital Expenditures	-152	-364	-193	-1,389	-687
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,386	138	-4,088	-1,069	-9,993
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1,538	-226	-4,281	-2,458	-10,680
Financing Cash Flow Items	-19	-54.3	472	-85.7	-337
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	1,578	-741	4,595	-2,440	12,071
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	217	241	2,371	-228	2,776